Advanced Search
Contact | Corporate | Help

A Study to Evaluate the Effects of Indacaterol Maleate as a New Formulation in the Concept 1 Device

Sponsors:
  • Novartis
Phases:
  • Phase II
IndicationsAcronym:
  • Asthma
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Indacaterol Maleate (high dose; Form 1) and Placebo (Form 2)
  • Drug: Placebo (Form 1) and Indacaterol Maleate (high dose; Form 2)
  • Drug: Placebo (Form 1) and Indacaterol Maleate (low dose; Form 2)
  • Drug: Placebo (Form 1) and Placebo (Form 2)
Enrollment:
36

Additional information about NCT01484197.


SourceSolution © 2008-2012